Novel Microdevices Overview
- Founded
- 2014
- Status
- Private
- Employees
- 25
- Latest Deal Type
- Series A
- Latest Deal Amount
- $2.42M
- Investors
- 3
Novel Microdevices General Information
Description
Developer of a handheld point-of-care medical device designed to facilitate molecular diagnostics. The company's device uses microfluidics to analyze a raw biological sample directly at the point of care and takes only 30 minutes to interpret quality results, enabling healthcare professionals to ensure accurate results in a lab-free environment.
Contact Information
Website
www.noveldx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- 6200 Seaforth Street
- Baltimore, MD 21224
- United States
+1 (443) 000-0000
Novel Microdevices Timeline
Novel Microdevices Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 01-Feb-2022 | $2.42M | 00.000 | Completed | Generating Revenue | |
| 2. Grant | 06-Apr-2021 | 00.00 | Completed | Generating Revenue | ||
| 1. Grant | $2M | Completed | Startup |
Novel Microdevices Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a handheld point-of-care medical device designed to facilitate molecular diagnostics. The company's device
Diagnostic Equipment
Baltimore, MD
25
As of 2022
00.000
00000000000
00.000
000000 0
r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
0000000000 000000000
Princeton, NJ
00
As of 0000
000
0000000000 0
000
000 0000
n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000 000000000
San Diego, CA
0000
As of 0000
00000
0.00
0000-00-00
00000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNovel Microdevices Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RICOVR Healthcare | Venture Capital-Backed | Princeton, NJ | 00 | 000 | 0000000000 0 | 000 |
| 000 000000 | Formerly VC-backed | San Diego, CA | 0000 | 00000 | 00000000 | 00000 |
| 000000000 | Venture Capital-Backed | Boulder, CO | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 000000 | Formerly VC-backed | Emeryville, CA | 000 | 00000 | 00000000 | 00000 |
| 0000000 0000000000 | Corporate Backed or Acquired | Carlsbad, CA | 000 | 0000 | 000000&0 | 0000 |
Novel Microdevices Patents
Novel Microdevices Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3111101-A1 | Sample-to-answer microfluidic system and method including vertical microfluidic device and automated actuation mechanisms | Pending | 27-Aug-2018 | 000000000000 | |
| EP-3843900-A1 | Sample-to-answer microfluidic system and method including vertical microfluidic device and automated actuation mechanisms | Pending | 27-Aug-2018 | 000000000 | |
| AU-2019327425-A1 | Sample-to-answer microfluidic system and method including vertical microfluidic device and automated actuation mechanisms | Pending | 27-Aug-2018 | 000000000000 | |
| US-20210178392-A1 | Sample-to-answer microfluidic system and method including vertical microfluidic device and automated actuation mechanisms | Pending | 27-Aug-2018 | 000000000000 | |
| CA-3045457-A1 | Automated point-of-care devices for complex sample processing and methods of use thereof | Pending | 01-Dec-2016 | B01L3/502715 |
Novel Microdevices Executive Team (5)
Novel Microdevices Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrea Pais | Novel Microdevices | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Steve Yannaras | Self | Board Member | 000 0000 |
Novel Microdevices Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNovel Microdevices Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CARB-X | University | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 |